ArticleOncoTargets and therapy2018

Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring

Yi-Long Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.